Tirzepatide becoming a dual GLP-1 and GIP agonist, it's suggested the GIP part of twin agonism could be liable for the additional reward, presented the potential benefit of GIP receptor agonism on peripheral insulin sensitization. As a result, tirzepatide was more practical than dulaglutide in reducing fasting dietary TAG [six,seven]. https://psychedelics54197.jts-blog.com/27601880/details-fiction-and-chemical-research-in-toxicology